| ID | 10379 |
| Vaccine Name | Bulgarian vaccine |
| Disease Name | Crimean-Congo haemorrhagic fever |
| Disease Classification | Hemorrhagic |
| Virus Name | Nairovirus |
| Nucleic Acid Content | negative-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Preclinical |
| Manufacturer | NA |
| Year of Manufacturing | 1974 |
| Manufacturing Country | Union of Soviet Socialist Republics |
| Age | 16 years and above |
| Dosage | NA |
| Administration Route | Subcutaneous |
| Adjuvant | Aluminum (aluminium hydroxide) |
| Target Strain | NA |
| Description | Prepared from brain tissue of CCHFV infected newborn mice |
| Approving Organisation | NA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | Zabdeno, Mvabea |
| PMID | 32461819 |
| Clinical Trial ID | NA |
| Reference Link | https://www.liebertpub.com/doi/10.1089/biores.2019.0057 |
| Additional Links | https://www.ema.europa.eu/en/documents/product-information/zabdeno-epar-product-information_en.pdf
|